Gateway Investment Advisers LLC Increases Stock Holdings in Humana Inc. $HUM

Gateway Investment Advisers LLC boosted its stake in Humana Inc. (NYSE:HUM) by 110.1% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,652 shares of the insurance provider’s stock after acquiring an additional 1,390 shares during the period. Gateway Investment Advisers LLC’s holdings in Humana were worth $1,053,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Fiduciary Alliance LLC lifted its position in shares of Humana by 0.9% in the 1st quarter. Fiduciary Alliance LLC now owns 5,628 shares of the insurance provider’s stock worth $976,000 after purchasing an additional 49 shares during the period. Sanctuary Advisors LLC increased its position in shares of Humana by 1.6% during the fourth quarter. Sanctuary Advisors LLC now owns 3,389 shares of the insurance provider’s stock valued at $868,000 after buying an additional 52 shares during the period. Horizon Investments LLC raised its stake in Humana by 2.5% in the fourth quarter. Horizon Investments LLC now owns 2,236 shares of the insurance provider’s stock worth $573,000 after buying an additional 55 shares in the last quarter. CoreCap Advisors LLC raised its stake in Humana by 74.7% in the second quarter. CoreCap Advisors LLC now owns 159 shares of the insurance provider’s stock worth $63,000 after buying an additional 68 shares in the last quarter. Finally, CENTRAL TRUST Co lifted its holdings in Humana by 36.5% in the fourth quarter. CENTRAL TRUST Co now owns 273 shares of the insurance provider’s stock worth $70,000 after buying an additional 73 shares during the period. 92.38% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on HUM shares. Leerink Partners upgraded Humana from a “market perform” rating to an “outperform” rating and set a $513.00 target price on the stock in a report on Thursday, July 30th. William Blair initiated coverage on Humana in a research note on Wednesday, May 20th. They issued an “outperform” rating for the company. Robert W. Baird set a $390.00 price target on Humana in a research report on Thursday, July 30th. Seaport Research Partners lowered Humana to a “neutral” rating in a research report on Wednesday, May 20th. Finally, JPMorgan Chase & Co. increased their price objective on Humana from $316.00 to $393.00 and gave the stock a “neutral” rating in a report on Monday. One analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, fourteen have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $395.22.

Humana Stock Up 4.3%

Shares of NYSE:HUM opened at $388.86 on Thursday. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62. The stock has a fifty day simple moving average of $380.56 and a two-hundred day simple moving average of $274.05. Humana Inc. has a 12-month low of $163.11 and a 12-month high of $428.88. The stock has a market capitalization of $46.69 billion, a price-to-earnings ratio of 36.79, a PEG ratio of 2.13 and a beta of 0.72.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, beating the consensus estimate of $7.27 by $0.34. The firm had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. Humana had a return on equity of 11.20% and a net margin of 0.88%.The company’s revenue was up 26.2% on a year-over-year basis. During the same period last year, the company earned $6.27 earnings per share. On average, research analysts anticipate that Humana Inc. will post 9.09 earnings per share for the current fiscal year.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.